Select Page

Meet The Team

The Founders

Anath Shalev, Founder

Anath Shalev, MD
Founder & Chief Scientific Officer

Professor of Medicine
Director, Comprehensive  Diabetes Center
Nancy R. and Eugene C. Gwaltney Family Endowed Chair in Juvenile Diabetes Research
University of Alabama at Birmingham

Mike Goodrich, Founder

T. Michael Goodrich, II, JD
President and Executive Board Chair

Manager
First Avenue Ventures Life Science, LLC
Birmingham, Alabama

The Scientific Advisory Board

G. Alexander Fleming

David M. Harlan, MD
Chair, Scientific Advisory Board & Executive Board Member

William and Doris Krupp Professor of Medicine
Director, UMass Diabetes Center of Excellence
Umass Memorial Health
Umass Chan Medical School

Brian Oscherwitz

Alan Moses, MD
Member, Scientific Advisory Board

Consultant
Senior Vice President and Chief Medical Officer of Joslin Diabetes Center (-2004)
Senior Vice President and Global Chief Medical Officer of Novo Nordisk (-2018)

Thomas Seoh, J.D.

C. Ronald Kahn, MD
Member, Scientific Advisory Board

Mary K. Iacocca Professor of Medicine, Harvard Medical School
Chief Academic Officer, Joslin Diabetes Center

Extended Team of Experts

G. Alexander Fleming

G. Alexander Fleming, MD
Strategic Regulatory & Clinical Development Expert

Brian Oscherwitz

Brian Oscherwitz, MBA, PMP
Operational Oversight

G. Alexander Fleming

Jo Van Betsbrugge, PhD
Chemistry, Manufacturing & Controls (CMC)

Brian Oscherwitz

Dave Edwards, PhD
Pre-Clinical Testing

Thomas Seoh, J.D.

Michael B. Zemel, PhD
Translational, Clinical & Regulatory Expert

TIXiMED Logo

Kinexium’s Drs. Fleming, Oscherwitz, Betsbrugge, Edwards, and Zemel have decades of experience helping guide life science companies in the diabetes and metabolism field in the design and implementation of FDA regulatory,  manufacturing, nonclinical and clinical drug development and business efforts, and are now working with TIXiMED.

Business Development

Business Development expert Stephen Daly.

Stephen Daly

30+ years of experience in pharma/biotech including 18+ years in diabetes and metabolism.

Amylin and Adocia logos.
Abvance Therapeutics logo.